Children with Down syndrome had eight times the cancer risk. In adults it vanished.

Whether people with intellectual disability get more cancer than everyone else has been an inconsistent literature for years. A cohort study published in Cancer Medicine in April uses Australian linked administrative and cancer registry data to answer it at population scale, and finds that the question was badly posed: the answer depends entirely on age [s1].

The design

The study linked population-based administrative and cancer registry data in New South Wales covering 2001 to 2018 [s1]. People with intellectual disability were compared against a comparator group without intellectual disability, matched for age, sex and residential postcode [s1]. A separate comparison examined people with Down syndrome against people with intellectual disability who did not have Down syndrome [s1]. Analysis used a flexible parametric survival model accounting for competing risks [s1].

Two design choices carry weight. Postcode matching is a partial proxy for socioeconomic position and health service access — imperfect, but better than no adjustment. And accounting for competing risks matters a great deal here, because people with intellectual disability have higher mortality from other causes, and a naive analysis would undercount cancers in people who died of something else first.

The headline is close to null

Across all ages, people with intellectual disability had a slightly higher risk of developing any cancer: a sub-hazard ratio of 1.07 (95% CI 1.03–1.12) compared with those without [s1].

That is a 7% relative increase — statistically significant in a cohort this size, and small enough that reporting it as the finding would be misleading. The age breakdown is the actual result.

The age inversion

In the 0-to-14 age group, the sub-hazard ratio was 2.19 (95% CI 1.85–2.59) [s1]. In the 15-to-49 group, 1.34 (95% CI 1.23–1.46) [s1]. And at 50 and above, the ratio fell below one: 0.93 (95% CI 0.88–0.98) [s1].

Cancer risk in people with intellectual disability was more than doubled in childhood, moderately elevated through mid-life, and lower than the comparator group after 50. Averaging those three into a single 1.07 conceals a reversal.

The over-50 finding is where interpretation should be most cautious. A lower measured cancer incidence can mean less cancer, or it can mean less cancer being found. People with intellectual disability face documented barriers to cancer screening participation, and an undiagnosed cancer does not appear in a registry. This study reports incidence of recorded diagnoses; it cannot distinguish genuinely lower biological risk from lower detection, and the abstract does not claim to.

Which cancers

By site, people with intellectual disability had a higher risk of colorectal cancer (SHR 1.32, 95% CI 1.15–1.51) and a lower risk of prostate cancer (SHR 0.45, 95% CI 0.38–0.53) and melanoma (SHR 0.75, 95% CI 0.64–0.88) [s1].

The prostate and melanoma results are instructive precisely because both are cancers whose recorded incidence is heavily driven by how much looking gets done. Prostate cancer diagnosis depends on PSA testing; melanoma diagnosis depends on skin examination. A sub-hazard ratio of 0.45 for prostate cancer is a very large deficit, and a detection explanation is at least as plausible as a biological one — though the study design cannot separate them.

Colorectal cancer being elevated while prostate cancer and melanoma are reduced fits a pattern where cancers that present symptomatically are found and cancers that require active screening are not. That is a hypothesis the data are consistent with, not one the study tests.

Down syndrome, and the childhood spike

People with Down syndrome had a significantly higher risk of childhood cancer than people with other intellectual disability — a sub-hazard ratio of 7.94 (95% CI 5.72–11.04) — and a similar risk as adults [s1].

An almost eightfold elevation in childhood, resolving to parity in adulthood, is a distinctive pattern, and it is consistent with the long-established association between Down syndrome and childhood leukaemia. The comparison here is against other people with intellectual disability rather than against the general population, which is the more informative contrast for the question of whether Down syndrome carries risk beyond intellectual disability itself. It does, in childhood.

It also means the childhood excess in the broader intellectual disability group is substantially driven by the Down syndrome subgroup within it — an important qualification on the 2.19 figure.

What the authors conclude

Their stated conclusion is a service one: the findings underscore the need for targeted health promotion campaigns and, for adults, customised cancer screening programmes to improve access, acceptability and outcomes for people with intellectual disability [s1].

The word "customised" is doing specific work. Australia's national screening programmes — bowel, breast, cervical — are designed around a standard invitation, a standard consent process and a standard procedure. The barrier for adults with intellectual disability is generally not the programme's existence but its format.

Limits

This is a registry study of one Australian state over 17 years. It measures recorded diagnoses, not underlying disease, and it reports incidence rather than survival or mortality — how people fared after diagnosis is not addressed here. Identification of intellectual disability comes from linked administrative data, which will capture people who had contact with the services generating those records and may miss others.

What to watch

The result that would resolve the central ambiguity is a screening participation analysis linked to the same cohort. If participation in bowel, breast and cervical screening is markedly lower in this population, the over-50 deficit and the prostate and melanoma findings read as detection artefacts rather than protection — and that reading changes what the policy response should be.

Sources

• [s1] Cancer Incidence in People With Intellectual Disability and Down Syndrome in Australia: A Cohort Study, Cancer Medicine, published online 29 April 2026. https://doi.org/10.1002/cam4.71866